RATIONALE: Biomass exposure is an important risk factor for chronic obstructive pulmonary disease (COPD). However, the time-course behavior of FEV1 in subjects exposed to biomass is unknown. OBJECTIVES: We undertook this study to determine the FEV1 rate decline in subjects exposed to biomass. METHODS: Pulmonary function was assessed every year in a Mexican cohort of patients with COPD associated with biomass or tobacco during a 15-year follow-up period. MEASUREMENTS AND MAIN RESULTS: The mean rate of decline was significantly lower for the biomass exposure COPD group (BE-COPD) than for the tobacco smoke COPD group (TS-COPD) (23 vs. 42 ml, respectively; P < 0.01). Of the TS-COPD group, 11% were rapid decliners, whereas only one rapid decliner was found in the BE-COPD group; 69 and 21% of smokers versus 17 and 83% of the BE-COPD group were slow decliners and sustainers, respectively. A higher FEV1 both as % predicted and milliliters was a predictive factor for decline for BE-COPD and TS-COPD, whereas reversibility to bronchodilator was a predictive factor for both groups when adjusted by FEV1% predicted and only for the TS-COPD group when adjusted by milliliters. CONCLUSIONS: In the biomass exposure COPD group the rate of FEV1 decline is slower and shows a more homogeneous rate of decline over time in comparison with smokers. The rapid rate of FEV1 decline is a rare feature of biomass-induced airflow limitation.
RATIONALE: Biomass exposure is an important risk factor for chronic obstructive pulmonary disease (COPD). However, the time-course behavior of FEV1 in subjects exposed to biomass is unknown. OBJECTIVES: We undertook this study to determine the FEV1 rate decline in subjects exposed to biomass. METHODS: Pulmonary function was assessed every year in a Mexican cohort of patients with COPD associated with biomass or tobacco during a 15-year follow-up period. MEASUREMENTS AND MAIN RESULTS: The mean rate of decline was significantly lower for the biomass exposure COPD group (BE-COPD) than for the tobacco smoke COPD group (TS-COPD) (23 vs. 42 ml, respectively; P < 0.01). Of the TS-COPD group, 11% were rapid decliners, whereas only one rapid decliner was found in the BE-COPD group; 69 and 21% of smokers versus 17 and 83% of the BE-COPD group were slow decliners and sustainers, respectively. A higher FEV1 both as % predicted and milliliters was a predictive factor for decline for BE-COPD and TS-COPD, whereas reversibility to bronchodilator was a predictive factor for both groups when adjusted by FEV1% predicted and only for the TS-COPD group when adjusted by milliliters. CONCLUSIONS: In the biomass exposure COPD group the rate of FEV1 decline is slower and shows a more homogeneous rate of decline over time in comparison with smokers. The rapid rate of FEV1 decline is a rare feature of biomass-induced airflow limitation.
Entities:
Keywords:
biomass exposure; lung function decline; phenotypes
Authors: Akshay Sood; Nour A Assad; Peter J Barnes; Andrew Churg; Stephen B Gordon; Kevin S Harrod; Hammad Irshad; Om P Kurmi; William J Martin; Paula Meek; Kevin Mortimer; Curtis W Noonan; Rogelio Perez-Padilla; Kirk R Smith; Yohannes Tesfaigzi; Tony Ward; John Balmes Journal: Eur Respir J Date: 2018-01-04 Impact factor: 16.671
Authors: Michael Guarnieri; Esperanza Diaz; Daniel Pope; Ellen A Eisen; Jennifer Mann; Kirk R Smith; Tone Smith-Sivertsen; Nigel G Bruce; John R Balmes Journal: Chest Date: 2015-11 Impact factor: 9.410
Authors: Fernando J Martinez; Alvar Agusti; Bartolome R Celli; MeiLan K Han; James P Allinson; Surya P Bhatt; Peter Calverley; Sanjay H Chotirmall; Badrul Chowdhury; Patrick Darken; Carla A Da Silva; Gavin Donaldson; Paul Dorinsky; Mark Dransfield; Rosa Faner; David M Halpin; Paul Jones; Jerry A Krishnan; Nicholas Locantore; Fernando D Martinez; Hana Mullerova; David Price; Klaus F Rabe; Colin Reisner; Dave Singh; Jørgen Vestbo; Claus F Vogelmeier; Robert A Wise; Ruth Tal-Singer; Jadwiga A Wedzicha Journal: Am J Respir Crit Care Med Date: 2022-02-01 Impact factor: 21.405
Authors: L Rey-Ares; V Irazola; F Althabe; E Sobrino; A Mazzoni; P Serón; F Lanas; M Calandreli; A Rubinstein Journal: Indoor Air Date: 2016-01-05 Impact factor: 5.770
Authors: Juan Manuel Reséndiz-Hernández; Raúl H Sansores; Rafael de Jesús Hernández-Zenteno; Gilber Vargas-Alarcón; Laura Colín-Barenque; Mónica Velázquez-Uncal; Angel Camarena; Alejandra Ramírez-Venegas; Ramcés Falfán-Valencia Journal: Int J Chron Obstruct Pulmon Dis Date: 2015-06-29
Authors: Alejandra Ramírez-Venegas; Francisco Montiel-Lopez; Ramces Falfan-Valencia; Gloria Pérez-Rubio; Raúl H Sansores Journal: Front Med (Lausanne) Date: 2021-07-08